Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Neocaine LLC currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is confined to 1 distinct art unit and involves 1 distinct examiner. Such a concentrated profile indicates that the company's current patent office interactions are limited to a single technical review group. The 1 pending office action represents the entirety of the company's current pending workload in this sector.
The individual examiner handling the 1 pending office action is WESTERBERG, NISSA M. Because the portfolio consists of only 1 matter, the company's prosecution strategy is entirely dependent on the interactions within this 1 distinct art unit. This streamlined data reflects a narrow point of contact between Neocaine LLC and the patent office. With 1 distinct examiner, the company can focus its resources on addressing the specific concerns raised by the assigned official for this single Biotechnology & Pharmaceuticals application.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WESTERBERG, NISSA M | 1 | 23.4% | +37.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19345876 | IMPROVED LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE | WESTERBERG, NISSA M | 3d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19345876 | IMPROVED LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE | WESTERBERG, NISSA M | 3d overdue |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19345876 | IMPROVED LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE | WESTERBERG, NISSA M | 1618 | §103 | Final Rejection | 3d overdue | Pending | Sep 30, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial